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Abstract
Purpose—Colorectal cancer is the second most common cause of cancer death in the United 
States, and rates of screening for colorectal cancer are low. We sought to gather the perceptions of 
clinic personnel at Latino-serving Federally Qualified Health Centers (operating 17 clinics) about 
barriers to utilization of screening services for colorectal cancer.
Method—We conducted one-on-one interviews among 17 clinic personnel at four Latino-serving 
Federally Qualified Health Center networks in Oregon. All interviews were recorded, transcribed, 
and coded, and themes were grouped by influences at three levels: the patient, the organization, 
and the external environment.
Results—Estimated proportions of eligible patients who are underscreened for colorectal cancer 
ranged from 20% to 70%. Underscreening was thought to occur among low-income, underinsured, 
and undocumented patients and patients having multiple health concerns. Limited funding to pay 
for follow-up testing in patients with positive screens was cited as the key factor contributing to 
underscreening.
Conclusions—We identified health care provider perceptions about the underutilization of 
screening services for colorectal cancer; our findings may inform future efforts to promote 
guideline-appropriate cancer screening.
Colorectal cancer is the second leading cause of cancer death in the United States, and 
regular screening can substantially reduce mortality from the disease (American Cancer 
Society, 2011). Data from randomized clinical trials show that regular screening can reduce 
colorectal cancer mortality by 33% (Mandel et al., 1993). The U.S. Preventive Services Task 
Force (2009) recommends regular colorectal cancer screening among men and women aged 
50 to 75 years using (a) annual high-sensitivity fecal occult blood testing, (b) colonoscopy 
every 10 years, or (c) sigmoidoscopy every 5 years combined with high-sensitivity fecal 
occult blood testing every 3 years. As of July 2012, colorectal cancer screening became a 
reportable Healthcare Effectiveness Data and Information Set measure, a measure used by 
more than 90% of U.S. health plans to monitor important aspects of care and service 
(National Committee for Quality Assurance, 2012). In 2010, colorectal cancer screening was 
included in the list of preventive services covered under the Affordable Care Act, which 
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mandates health care plan coverage of screening without patient copays (U.S. Department of 
Health and Human Services, 2012).
Nevertheless, rates of screening are low in the general population, and particularly low in 
certain population subgroups.
Data from the National Health Interview Survey show that in 2010, only 57% of the U.S. 
population was adherent with colorectal cancer screening recommendations, with 
particularly low rates among Hispanics (47% vs. 60% for non-Hispanic Whites), those 
lacking insurance (21% vs. 65% for those having private or military insurance), and those 
having lived in the United States for fewer than 10 years (21% vs. 61% for U.S. born; 
Centers for Disease Control and Prevention, 2012). Notably, the subgroups least likely to be 
up-to-date with screening are those who receive preventive care services, including 
colorectal cancer screening, at one of 8,147 Federally Qualified Health Center (FQHC) 
delivery sites nationwide.
A limited number of qualitative and quantitative reports have examined patient-level factors 
that contribute to low colorectal screening participation. Available data show low patient 
awareness of colorectal cancer and the importance of screening (Goldman, Diaz, & Kim, 
2009; Goodman, Ogdie, Kanamori, Canar, & O’Malley, 2006; Robinson et al., 2011), lack 
of a physician recommendation for screening (Feeley, Cooper, Foels, & Mahoney, 2009; 
Hoffman et al., 2011; Lasser, Ayanian, Fletcher, & Good, 2008; Robinson et al., 2011), fear 
of pain associated with the test (Getrich et al., 2012; Hoffman et al., 2011; Janz et al., 2007; 
Kelly et al., 2007), having no symptoms (Lasser et al., 2008), and feelings of embarrassment 
about the test (Hoffman et al., 2011; Kelly et al., 2007). Some patients are thought to face 
financial barriers, perceive the test as costly, or fear incurring costs of diagnostic follow-up 
(Goodman et al., 2006; Harden, Moore, & Melvin, 2011).
Less is known about organizational-level factors that contribute to low rates of colorectal 
cancer screening. Available data from community-based primary care practices show lack of 
provider time, patient reluctance, and the lack of referral and treatment sources for 
colonoscopy for follow-up of abnormal fecal occult blood testing (FOBT) as major barriers 
to the initiation of colorectal cancer screening (Feeley et al., 2009; Goodman et al., 2006; 
O’Malley, Beaton, Yabroff, Abramson, & Mandelblatt, 2004). Even less is known about 
organizational-level factors at play in clinics that specialize in services for Latino patients. 
Klabunde et al. (2009) report on colorectal cancer screening attitudes and practices from a 
national survey of 1,235 physicians; however, these interviews were not restricted to 
physicians serving low-income or Latino patients.
We sought to understand perspectives on colorectal cancer screening among clinic personnel 
who work in FQHCs that specialize in the delivery of primary care services for Latino 
patients. Our objectives were to understand clinical perspectives on the reasons patients do 
not obtain screening and to identify elements for a future intervention to raise rates of 
colorectal cancer screening. Few previous investigations have explored these issues in 
FQHCs in general, and among Latino-serving FQHCs in particular.
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Our study involved four Latino-serving FQHCs operating 17 medical clinics that deliver 
primary care services. Together, the clinics serve more than 94,410 unique clients each year, 
of which 45% are Latino and 19.2% are aged 50 to 75 years. Among patients aged 50 to 75 
years, 20.9% were on Medicaid and 36.4% were uninsured.
Data Collection
Medical and clinical support staff were recruited using a purposive sampling technique, with 
the goal of interviewing a family physician, nurse, medical assistant, and outreach worker 
from each site. In some cases, the family physician served in the role of medical director. 
We developed a 15-item, semistructured interview schedule that addressed colorectal cancer 
screening practices and factors associated with underutilization of screening services. 
Interviews lasted about 1 hour, and all clinics were offered a monetary incentive as 
compensation for their staff members’ time. Interviews were conducted between July 2011 
and May 2012. All interviews were audio recorded and transcribed verbatim. We used a 
qualitative content analysis approach (Elo & Kyngas, 2008; Graneheim & Lundman, 2004) 
and grounded theory to develop codes (Elo & Kyngas, 2008; Graneheim & Lundman, 
2004). All transcripts were coded by three trained coders. Themes were grouped, according 
to aspects of the socioecological framework (Centers for Disease Control and Prevention, 
2013), by influences at the patient and organizational levels and the external environment. 
To assure the accuracy of our findings, a draft manuscript was circulated to all participating 
medical directors, and feedback was solicited to ensure accuracy of our interpretations (i.e., 
member check). All interviews were conducted by two project staff: a psychologist trained 
in qualitative data collection and the project principal investigator. All study procedures 
were reviewed by the institutional review board at the Kaiser Permanente Center for Health 
Research and qualified for a waiver of consent.
Results
A total of 17 providers were interviewed, including four physicians, two nurse practitioners, 
three registered nurses, five medical assistants, two outreach coordinators, and one 
operations director (Table 1). The mean age was 45 years; respondents were mostly female, 
and two thirds were non-Hispanic White. The mean numbers of years in role was 13 years.
Clinic personnel reported that the proportion of age-eligible patients who received colorectal 
cancer screening less frequently than recommended ranged from 20% to 70%. None 
reported that patients were screened more frequently than recommended. Several factors 
were thought to influence low screening adherence (Table 2).
Patient-Level Factors
Clinic personnel reported that patients had a low awareness of the need for colorectal cancer 
screening and the benefits of early colorectal cancer detection. One clinic personnel noted,
There is an element in the Hispanic population to a degree … of
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… you know, not recognizing that cancer caught early is curable. (Registered 
nurse)
Clinic personnel perceived that patients feared receiving a positive screening result and that 
patients thought the test was unpleasant (clinic personnel did not distinguish between a fecal 
test and colonoscopy). One clinic personnel noted,
[The test] … it’s not particularly pleasant. It’s expensive. I think there’re just 
barriers, a lot of barriers. (Physician)
Lacking health care insurance and having a low income were perceived as patient barriers to 
receiving colorectal cancer screening.
Organizational-Level Factors
In general, clinic personnel had concerns that patients who were given an FOBT during a 
clinic appointment would not complete the test. One clinic personnel noted:
I can think of 2 or 3 patients this year that I’ve referred and they’ve been set up for 
the initial consultation and then they either go to that and they don’t follow up or 
they don’t go to that and those are patients with insurance.
Several clinic personnel expressed intentions to adopt the use of fecal immunochemical 
testing in their clinical practices. Most providers expressed optimism that the new test, 
which generally relies on the collection of fewer stool samples, would increase patient 
participation in screening. Other concerns were limited time during the clinic visit to discuss 
colorectal cancer screening, providers’ belief that patients will not adhere to 
recommendations for colonoscopy, providers needing to prioritize patients’ acute health 
concerns, and limited clinical resources (e.g., too few clinical staff to serve patient needs).
External Factors
An overwhelming concern of clinic personnel was the high cost of colonoscopy and limited 
patient resources to pay for it. Limited access to colonoscopy services (few available 
specialists, high cost of colonoscopy, inconsistent patient follow-up) was a key factor that 
impeded providers from initiating screening. Some providers expressed interest in retaining 
patient care within their clinic and a concern that referring sites that perform colonoscopy 
offer no sliding fee scales and low-cost care options for patients. Even among insured 
patients, clinic personnel perceived a low likelihood that patients would receive 
recommended follow-up care. One participant noted,
Even if you have insurance, it takes about 9 months for a routine colonoscopy in 
this community. Usually, to get a colonoscopy with any speed, you need some 
reason. (Medical director)
Some providers noted long wait times to make appointments and difficulty in obtaining 
colonoscopy services. Providers also noted few available community resources to aid 
patients in paying for screening.
Most clinic personnel reported offering fecal testing to patients beginning at age 50. Some 
clinics were using a pre-visit review or “scrub” process where clinic staff reviews patient 
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records in advance of clinic appointment to identify disease management and preventive 
care needs; however, only one reported scrubbing for colorectal cancer screening, 
specifically. This process was perceived as effective at recruiting patients for screening. 
Apart from identifying patients with standing clinic visits who are eligible for screening, no 
other systems were in place to remind patient to complete screening or proactively recruit 
them into screening programs.
Discussion
We sought to understand clinic personnel’s perceptions of the extent to which 
underutilization of colorectal cancer screening occurs. Clinic personnel report high 
proportions of underutilization, ranging from 20% to 70%. Many reported providing home-
based FOBT cards during clinic visits. Limited funding to pay for follow-up testing in 
patients with positive screens was cited as a key factor contributing to underscreening. No 
respondent believed that patients were overscreened for colorectal cancer. As mandates of 
the Affordable Care Act emphasize affordable, coordinated, and accountable care, 
interventions to promote appropriate use of screening will become increasingly important.
Our findings reveal important factors that contribute to the underutilization of colorectal 
screening services: The most notable is limited access to colonoscopy services. Our 
respondents noted limitations in (a) resources to pay for screening, (b) access to follow-up 
care, and (c) specialists to perform needed exams. The high patient burden of the exam also 
meant that even insured patients were sometimes nonadherent with colonoscopy testing.
This finding is corroborated by previous literature; in separate qualitative reports involving 
African Americans,Harden et al. (2011) and O’Malley et al. (2004) cite perceived cost of 
diagnostic follow-up as a barrier to initial screening, a finding that was further corroborated 
in qualitative interviews with providers serving the same patients (O’Malley et al., 2004). 
Goodman et al. (2006) conducted focus groups involving 70 Latino patients and 27 primary 
care providers. Findings showed that providers and patients repeatedly cited as key barriers 
to screening the lack of funding and referral sources for colonoscopy; even when lower cost 
fecal testing was used as first-line screening, colonoscopy follow-up was thought to be 
unavailable.
Zapka, Taplin, Price, Cranos, and Yabroff, (2010) emphasize that health disparities can 
result from care gaps that often occur along the transitions of the cancer continuum. In the 
case of colorectal cancer screening, for example, disparate rates of participation in 
diagnostic care or delays in treatment can occur when patients are referred to a specialty care 
facility for a colonoscopy but there is a lack of systems to support their receipt of follow-up 
care. These gaps are more likely to occur when patient care is transferred across health 
system entities.
Our findings might suggest that improved access to follow-up colonoscopies is needed 
among patients who screen positive on fecal testing. In the regions served by these clinics, 
community organizations provide colonoscopies through a system of donated care, and 
some community hospitals provide such services. However, these programs were not 
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reported to be routinely used by providers we interviewed and were perceived as having 
insufficient capacity to meet the demand.
It is important to note that systems-based strategies to raise the rates of colorectal cancer 
screening were rarely mentioned by the individuals we interviewed. Although several clinics 
had outreach programs to raise community awareness about health topics, none reported 
addressing colorectal cancer screening. Moreover, programs to assure that patients who were 
provided a fecal test during a clinic visit mailed in their completed test were rarely 
mentioned.
Also not mentioned were programs to proactively recruit patients into screening programs, 
apart from patients with clinic visits who are identified during the scrub process. Previous 
reports have highlighted successes with systems-based strategies, including using team-
based approaches (O’Malley et al., 2004), chart reminders or flow sheets to identify patients 
in need of screening (Feeley et al., 2009; O’Malley et al., 2004), and direct-mail programs to 
promote at-home testing among patients without clinic visits (Coronado, Golovaty, Longton, 
Levy, & Jimenez, 2011; Green et al., 2013).
The National Cancer Institute and the Agency for Healthcare Research and Quality 
sponsored a review of colorectal cancer screening implementation in primary care. The 
review concluded that improvements in rates of colorectal cancer screening largely depend 
on efforts of primary care practices to implement effective systems and procedures for 
screening delivery. Recommended components of such systems were the following: (a) a 
team approach, (b) information systems to identify eligible patients and remind them to get 
screened, (c) involving patients in the decision about their care, (d) monitoring practice 
performance, (e) reimbursement for services outside of the medical encounter (e.g., 
telephone and e-mail contacts), and (f) training providers in communication, cultural 
competence, and use of information systems (Klabunde et al., 2007).
Such systems-based strategies may be needed to elevate rates of colorectal cancer screening 
in this clinic population. Our findings, however, suggest that establishing strong referral 
processes so that patients screened in FQHC can obtain necessary follow-up care may be 
needed first.
Limitations
This study has limitations that deserve mention. Our convenience sampling of participants 
means that our data cannot be widely generalized; however, our inclusion of several clinics 
means that it is more generalizable than most qualitative reports. Our interviews were 
complete prior to July 2012, at which time colorectal cancer screening became a reportable 
Healthcare Effectiveness Data and Information Set measure, which has been shown in some 
reports to incentivize screening. Moreover, our data represent perceptions of clinic 
personnel, an important aspect in designing clinic-based activities, though additional 
quantitative data should also be considered.
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Our findings highlight key factors to address in future efforts to implement evidence-based 
clinical practices for the prevention of cancer. Further research is needed to confirm and 
quantify the extent of underutilization of services for the prevention of colorectal cancer.
Acknowledgments
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of 
this article: This publication was supported in part by the Centers for Disease Control and Prevention (CDC) and 
the National Cancer Institute through the Cancer Prevention and Control Research Network, a network within the 
CDC’s Prevention Research Centers Program (Grant U48-DP-001911).
References
American Cancer Society. Colorectal cancer facts & figures 2011–2013. 2011 Retrieved from http://
www.cancer.org/research/cancerfactsfigures/colorectalcancerfactsfigures/colorectal-cancer-facts-
figures-2011-2013-page. 
Centers for Disease Control and Prevention. Cancer screening: United States 2010. Morbidity and 
Mortality Weekly Report. 2012; 61(3):41–45. Retrieved from http://www.cdc.gov/mmwr/preview/
mmwrhtml/mm6103a1.htm. [PubMed: 22278157] 
Centers for Disease Control and Prevention. Colorectal cancer control program: Social ecological 
model. 2013. Retrieved from http://www.cdc.gov/cancer/crccp/sem.htm
Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal 
cancer screening promotion program for underserved Hispanics. Cancer. 2011; 117:1745–1754. 
[PubMed: 21472722] 
Elo S, Kyngas H. The qualitative content analysis process. Journal of Advanced Nursing. 2008; 
62:107–115. [PubMed: 18352969] 
Feeley TH, Cooper J, Foels T, Mahoney MC. Efficacy expectations for colorectal cancer screening in 
primary care: Identifying barriers and facilitators for patients and clinicians. Health 
Communication. 2009; 24:304–315. [PubMed: 19499424] 
Getrich CM, Sussman AL, Helitzer DL, Hoffman RM, Warner TD, Sanchez V. RIOS Net Clinicians. 
Expressions of machismo in colorectal cancer screening among New Mexico Hispanic 
subpopulations. Qualitative Health Research. 2012; 22:546–559. [PubMed: 22138258] 
Goldman RE, Diaz JA, Kim I. Perspectives of colorectal cancer risk and screening among Dominicans 
and Puerto Ricans: Stigma and misperceptions. Qualitative Health Research. 2009; 19:1559–1568. 
[PubMed: 19776255] 
Goodman MJ, Ogdie A, Kanamori MJ, Canar J, O’Malley AS. Barriers and facilitators of colorectal 
cancer screening among Mid-Atlantic Latinos: Focus group findings. Ethnicity & Disease. 2006; 
16:255–261. [PubMed: 16599380] 
Graneheim UH, Lundman B. Qualitative content analysis in nursing research: Concepts, procedures 
and measures to achieve trustworthiness. Nurse Education Today. 2004; 24:105–112. [PubMed: 
14769454] 
Green BB, Wang CY, Anderson ML, Chubak J, Meenan RT, Vernon SW, Fuller S. An automated 
intervention with stepped increases in support to increase uptake of colorectal cancer screening: A 
randomized trial. Annals of Internal Medicine. 2013; 158(5 Pt. 1):301–311. [PubMed: 23460053] 
Harden E, Moore A, Melvin C. Exploring perceptions of colorectal cancer and fecal immunochemical 
testing among African Americans in a North Carolina community. Preventing Chronic Disease. 
2011; 8(6):A134. Retrieved from http://www.cdc.gov/pcd/issues/2011/nov/10_0234.htm. 
[PubMed: 22005627] 
Coronado et al. Page 7













Hoffman RM, Rhyne RL, Helitzer DL, Stone SN, Sussman AL, Bruggeman EE, Warner TD. Barriers 
to colorectal cancer screening: physician and general population perspectives, New Mexico, 2006. 
Preventing Chronic Disease. 2011; 8(2):A35. [PubMed: 21324249] 
Janz NK, Lakhani I, Vijan S, Hawley ST, Chung LK, Katz SJ. Determinants of colorectal cancer 
screening use, attempts, and non-use. Preventive Medicine. 2007; 44:452–458. [PubMed: 
17196247] 
Kelly KM, Phillips CM, Jenkins C, Norling G, White C, Jenkins T, Dignan M. Physician and staff 
perceptions of barriers to colorectal cancer screening in Appalachian Kentucky. Cancer Control. 
2007; 14:167–175. [PubMed: 17387302] 
Klabunde CN, Lanier D, Breslau ES, Zapka JG, Fletcher RH, Ransohoff DF, Winawer SJ. Improving 
colorectal cancer screening in primary care practice: Innovative strategies and future directions. 
Journal of General Internal Medicine. 2007; 22:1195–1205. [PubMed: 17534688] 
Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by 
primary care physicians: recommendations and practices, 2006–2007. American Journal of 
Preventive Medicine. 2009; 37(1):8–16. [PubMed: 19442479] 
Lasser KE, Ayanian JZ, Fletcher RH, Good MJ. Barriers to colorectal cancer screening in community 
health centers: A qualitative study. BMC Family Practice. 2008; 9:15. [PubMed: 18304342] 
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing 
mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer 
Control Study. New England Journal of Medicine. 1993; 328:1365–1371. Retrieved from http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi?
cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8474513. [PubMed: 8474513] 
National Committee for Quality Assurance. HEDIS & quality measurement. 2012 Retrieved from 
http://www.ncqa.org/tabid/59/Default.aspx. 
O’Malley AS, Beaton E, Yabroff KR, Abramson R, Mandelblatt J. Patient and provider barriers to 
colorectal cancer screening in the primary care safety-net. Preventive Medicine. 2004; 39:56–63. 
[PubMed: 15207986] 
Robinson CM, Cassells AN, Greene MA, Beach ML, Tobin JN, Dietrich AJ. Barriers to colorectal 
cancer screening among publicly insured urban women: No knowledge of tests and no clinician 
recommendation. Journal of the National Medical Association. 2011; 103:746–753. [PubMed: 
22046852] 
U.S. Department of Health and Human Services. About the law. 2012. Retrieved from http://
www.hhs.gov/healthcare/rights/index.html
U.S. Preventive Services Task Force. Screening for colorectal cancer (Topic Page). 2009 Retrieved 
from http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm. 
Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R. Factors in quality care—the case of follow-up to 
abnormal cancer screening tests—problems in the steps and interfaces of care. Journal of the 
National Cancer Instsitute. Monographs. 2010; 2010(40):58–71.
Coronado et al. Page 8

























Coronado et al. Page 9
Table 1
Demographic Characteristics of Clinic Personnel (n = 17).
Characteristic N (%)
Clinical sites 17
Mean age, years (range) 45.1 (29–63)
Gender
   Female 15 (94)
Race/ethnicity
   Non-Hisjpanic White 11 (65)
   Latino 6 (35)
Profession
   Family physician 4 (24)
   Nurse practitioner/registered nurse 5 (29)
   Medical assistant/licensed practical nurse 5 (29)
   Community health worker/out reach worker/other 3 (18)
Mean years in practice/role (range) 12.6 (1–33)
Mean years at present clinic (range) 10.0 (1–33)
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Table 2
Categories, Themes, and Illustrative Quotes Obtained From Narratives of Clinic Personnel.
Categories/Themes Illustrative Quotes
Individual (patient-level) factors
• Low awareness of colorectal cancer and the need for 
screening
• Psychosocial factors (fear/anxiety)
• Low-income, uninsured
• Testis perceived as unpleasant
“There is an element in the Hispanic population to a degree—you know,
not recognizing that cancer caught early is curable.” (Registered nurse)
“I think it’s the knowledge. I think if they knew what usually happens and
what can cause, I think they would be more willing to do it versus
not.” (Medical assistant)
“… just sort of seems insurmountable to get the population of under
100% of poverty to think about going and paying for a colonoscopy.”
(Physician)
“Definitely the uninsured don’t get a colonoscopy, or I shouldn’t say
“don’t get,” but it’s much harder for them to come up with the
resources to go and get the test.” (Nurse practitioner)
Organizational factors
• Low patient adherence to referral to colonoscopy
• Conversion to fecal immunochemical testing may 
improve screening rates
• Providers have limited time
• Providers must address patients’ more acute concerns
• Limited clinic resources (panel sizes too large, unable 
to recruit/retain providers)
“I can think of 2 or 3 patients this year that I’ve referred and they’ve been
set up for the initial consultation and then they either go to that and
they don’t follow up or they don’t go that and those are patients with
insurance.“ (Physician)
“We are the clinic where people would come for quick care. We’re trying
to follow people more than we’ve done in the past to do prevention,
but we’ve really had to also put out fires for people to keep them out of
the ER. We’re trying to do both, and that’s why our access is so tight.”
Licensed practical nurse)
“You know, it’s not particularly pleasant. It’s expensive. I think there’re
just barriers, a lot of barriers.” (Physician)
External factors
• High cost of exam (colonoscopy)
• Limited access to follow-up colonoscopies
○ Limited number of facilities that provide 
colonoscopies
○ Facilities that provide colonoscopy rarely 
offer sliding fee scales
○ Limited community resources to pay for 
colonoscopies for the uninsured
“I hear a lot of frustration from doctors that want to have their patient
have the colonoscopy and it’s just not happening. It’s really an expensive
exam …” (Nurse practitioner)
“Even if you have insurance … it takes about nine months for a routine
colonoscopy in this community. Usually, to get a colonoscopy with any
speed, you need some reason.” (Medical director)
“People say, “What if I found something out? Then where would I be
because I would never go get it treated? Why would I want to test
knowing I would have to carry that burden, you know?” (Registered
nurse—manager)
“So, (one program) is helpful for colonoscopy for the very, very, very
indigent. That’s a good thing. I don’t know of any other programs for
colonoscopy.” (Registered nurse-manager)
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